Global Academic Program 2020Global Academic Program 2020
Registration
Abstracts
  • Call for Abstracts
  • Themes
  • Poster Updates/Information
  • Home
  • Speakers & Program
    • Conference Handbook
    • Program
    • Plenary Speakers
    • Concurrent Sessions
  • Sponsorship
    • Our Sponsors and Exhibitors
    • Our Supporting Organisations
  • Contact
    • Contact
    • Privacy Policy
  • Online Event
    • Poster Session Guidelines
    • Speaker/Chair Guidelines
    • Tips for Recording a Presentation
  • Virtual Portal Help
  • Home
  • Speakers & Program
    • Conference Handbook
    • Program
    • Plenary Speakers
    • Concurrent Sessions
  • Sponsorship
    • Our Sponsors and Exhibitors
    • Our Supporting Organisations
  • Contact
    • Contact
    • Privacy Policy
  • Online Event
    • Poster Session Guidelines
    • Speaker/Chair Guidelines
    • Tips for Recording a Presentation
  • Virtual Portal Help

Patrick Hwu, M.D.

Patrick Hwu, M.D.

Department of Melanoma Medical Oncology, Division of Cancer Medicine

Dr. Patrick Hwu is a tumor immunologist focused on the areas of vaccines, adoptive T-cell therapies, and immune resistance. His research and clinical efforts have led to insights and advances in the understanding of the interactions between tumors and the immune system, and the development of cellular therapies. He is the principal investigator on several NIH R01 translational immunotherapy grants, and other peer-reviewed grants. Several novel, ongoing clinical trials have resulted based on his group’s work, which include a trial of T-cells modified with chemokine receptor genes to enhance their migration to the tumor. Most recently, his preclinical studies have focused on combinations of immune checkpoint blockade and T-cell therapy, as well as rational combinations of targeted therapies and immunotherapies. Both of these concepts are being moved into the clinic to improve treatment outcomes for our patients.

Dr. Hwu earned his medical degree from the Medical College of Pennsylvania in Philadelphia. Following his service as a house officer in Internal Medicine at The Johns Hopkins Hospital, he completed a fellowship in oncology at the National Cancer Institute, where he continued to work for 10 years as a Principal Investigator leading tumor immunology studies. In addition, he has been Chair of the Department of Sarcoma Medical Oncology since June 2012. Most recently, he accepted the appointment of Head of the Division of Cancer Medicine, March 4, 2015. In recognition of his outstanding contributions to cancer research, Dr. Hwu has held endowed positions since joining the institution. He currently holds the Sheikh Mohammed Bin Zayed Al Nahyan Distinguished University Chair at MD Anderson Cancer Center.

Peter Mac Organising Committee

Ms Jac Mathieson
Associate Professor Kate Burbury
Professor Ricky Johnstone
Yvonne Panek-Hudson
Professor Mark Rosenthal
Associate Professor Jayesh Desai
Professor Michael Henderson
Professor Bernhard Riedel
Associate Professor Gerry Hanna

MD Anderson Organising Committee

Sarah Berger
Jeffrey Gershenwald
Patty Johnston
Michael Kupferman
La Chanda Ricks

FOLLOW US ON TWITTER #GAP_2020

Tweets by GAP_2020

CONNECT WITH US


Leishman Associates
227 Collins St, HOBART TAS 7000
P: 03 6234 7844
F: 03 6234 5958
E: brittany@laevents.com.au
W: leishman-associates.com.au

© Copyright 2020 Global Academic Program 2020. All Rights Reserved